Karuna Mittal

758 total citations
27 papers, 443 citations indexed

About

Karuna Mittal is a scholar working on Cancer Research, Oncology and Cell Biology. According to data from OpenAlex, Karuna Mittal has authored 27 papers receiving a total of 443 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Cancer Research, 14 papers in Oncology and 11 papers in Cell Biology. Recurrent topics in Karuna Mittal's work include Microtubule and mitosis dynamics (11 papers), Cancer Genomics and Diagnostics (11 papers) and Breast Cancer Treatment Studies (6 papers). Karuna Mittal is often cited by papers focused on Microtubule and mitosis dynamics (11 papers), Cancer Genomics and Diagnostics (11 papers) and Breast Cancer Treatment Studies (6 papers). Karuna Mittal collaborates with scholars based in United States, United Kingdom and Norway. Karuna Mittal's co-authors include Ritu Aneja, Padmashree C.G. Rida, Meenakshi V. Gupta, Michelle D. Reid, Emad A. Rakha, Michael S. Toss, Ramneet Kaur, Ian O. Ellis, Kylie L. Gorringe and Andrew R. Green and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Scientific Reports.

In The Last Decade

Karuna Mittal

27 papers receiving 439 citations

Peers

Karuna Mittal

ONCOL

PRM

María Giselle Peters Argentina

Mark J. Schliekelman United States

Brunella Costanza Belgium

Eslam A. Elghonaimy Egypt

Sahra Borgés United States

Leili Saeednejad Zanjani Iran

Natascha Cremers Germany

Sara Koenig McLaughlin United States

Xia-Ying Kuang China

Nina Goerner Spain

María Giselle Peters Argentina

Karuna Mittal

300 ×1.2

120 ×0.6

177 ×1.0

ONCOL

89 ×0.5

51 ×0.8

PRM

Citations per year, relative to Karuna Mittal Karuna Mittal (= 1×) peers María Giselle Peters

Countries citing papers authored by Karuna Mittal

Since Specialization

Citations

This map shows the geographic impact of Karuna Mittal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karuna Mittal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karuna Mittal more than expected).

Fields of papers citing papers by Karuna Mittal

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karuna Mittal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karuna Mittal. The network helps show where Karuna Mittal may publish in the future.

Co-authorship network of co-authors of Karuna Mittal

This figure shows the co-authorship network connecting the top 25 collaborators of Karuna Mittal. A scholar is included among the top collaborators of Karuna Mittal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karuna Mittal. Karuna Mittal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Rabinovitch, Rachel, Frank A. Vicini, Chirag Shah, et al.. (2023). Abstract PD15-07: PD15-07 7-gene predictive biosignature improves risk stratification for breast ductal carcinoma in situ patients compared to clinicopathologic criteria, identifying a low risk group not clinically benefiting from adjuvant radiotherapy. Cancer Research. 83(5_Supplement). PD15–7. 1 indexed citations

Dabbs, David J., Karuna Mittal, Pat W. Whitworth, et al.. (2023). Analytical validation of the 7-gene biosignature for prediction of recurrence risk and radiation therapy benefit for breast ductal carcinoma in situ. Frontiers in Oncology. 13. 1069059–1069059. 2 indexed citations

Vicini, Frank A., G. Bruce Mann, Chirag Shah, et al.. (2022). A Novel Biosignature Identifies Patients With DCIS With High Risk of Local Recurrence After Breast Conserving Surgery and Radiation Therapy. International Journal of Radiation Oncology*Biology*Physics. 115(1). 93–102. 14 indexed citations

Xu, Qi, Jaspreet Kaur, Dennis Wylie, et al.. (2022). A Case Series Exploration of Multi-Regional Expression Heterogeneity in Triple-Negative Breast Cancer Patients. International Journal of Molecular Sciences. 23(21). 13322–13322. 6 indexed citations

Mittal, Karuna, Jaspreet Kaur, Shrikant Pawar, et al.. (2021). Hypoxia Drives Centrosome Amplification in Cancer Cells via HIF1α-dependent Induction of Polo-Like Kinase 4. Molecular Cancer Research. 20(4). 596–606. 13 indexed citations

Mittal, Karuna, Michael S. Toss, Jaspreet Kaur, et al.. (2020). A Quantitative Centrosomal Amplification Score Predicts Local Recurrence of Ductal Carcinoma In Situ. Clinical Cancer Research. 26(12). 2898–2907. 3 indexed citations

Mittal, Karuna, Jaspreet Kaur, Michael S. Toss, et al.. (2020). Centrosome amplification: a quantifiable cancer cell trait with prognostic value in solid malignancies. Cancer and Metastasis Reviews. 40(1). 319–339. 29 indexed citations

Toss, Michael S., Islam M. Miligy, Kylie L. Gorringe, et al.. (2019). Prognostic significance of cathepsin V (CTSV/CTSL2) in breast ductal carcinoma in situ. Journal of Clinical Pathology. 73(2). 76–82. 37 indexed citations

Toss, Michael S., Islam M. Miligy, Kylie L. Gorringe, et al.. (2019). Geometric characteristics of collagen have independent prognostic significance in breast ductal carcinoma in situ: an image analysis study. Modern Pathology. 32(10). 1473–1485. 20 indexed citations

10.

Toss, Michael S., Islam M. Miligy, Kylie L. Gorringe, et al.. (2019). Collagen (XI) alpha-1 chain is an independent prognostic factor in breast ductal carcinoma in situ. Modern Pathology. 32(10). 1460–1472. 28 indexed citations

11.

Toss, Michael S., Islam M. Miligy, Kylie L. Gorringe, et al.. (2019). The prognostic significance of lysosomal protective protein (cathepsin A) in breast ductal carcinoma in situ. Histopathology. 74(7). 1025–1035. 19 indexed citations

12.

Mittal, Karuna, et al.. (2019). Abstract P5-18-02: A quantitative centrosomal amplification score (CAS) predicts local recurrence in ductal carcinoma in situ. Cancer Research. 79(4_Supplement). P5–18. 2 indexed citations

13.

Mittal, Karuna, et al.. (2018). KIFC1 as a novel therapeutic target for p53 mutant colorectal cancer.. Journal of Clinical Oncology. 36(15_suppl). e15585–e15585. 1 indexed citations

14.

Mittal, Karuna, Ramneet Kaur, Chunhua Yang, et al.. (2017). Multinucleated polyploidy drives resistance to Docetaxel chemotherapy in prostate cancer. British Journal of Cancer. 116(9). 1186–1194. 98 indexed citations

15.

Mittal, Karuna, Angela Ogden, Meenakshi V. Gupta, et al.. (2017). Amplified centrosomes and mitotic index display poor concordance between patient tumors and cultured cancer cells. Scientific Reports. 7(1). 43984–43984. 18 indexed citations

16.

Mittal, Karuna, Sergey Klimov, Shrikant Pawar, et al.. (2016). A centrosome clustering protein, KIFC1, predicts aggressive disease course in serous ovarian adenocarcinomas. Journal of Ovarian Research. 9(1). 17–17. 46 indexed citations

17.

Mittal, Karuna, Sergey Klimov, Shrikant Pawar, et al.. (2016). A centrosome clustering protein, KIFC1, predicts aggressive disease course in serous ovarian adenocarcinomas. IUScholarWorks (Indiana University). 2 indexed citations

18.

Mittal, Karuna, et al.. (2016). Effect of mind body therapy (yoga, meditation & music) on elderly hypertensive people. 3(3). 108–108. 3 indexed citations

19.

Mittal, Karuna, et al.. (2015). Abstract B05: Centrosomal profiles of pancreatic adenocarcinoma from African American and European American patients: A comparative analysis. Cancer Epidemiology Biomarkers & Prevention. 24(10_Supplement). B05–B05. 1 indexed citations

20.

Aneja, Ritu, Karuna Mittal, Vaishali Pannu, et al.. (2015). A centrosome clustering protein, HSET, as a potential biomarker for ovarian adenocarcinomas.. Journal of Clinical Oncology. 33(15_suppl). e16562–e16562. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact